Logo Preclinical and Clinical Research & Development,
and Pharmaceutical Marketing
The management team | Picture gallery
Preclinical research | Clinical research

Licencing



Patents to outlicense:

A new patent is available for outlicensing:
"Use of enhancers of biglycan activity in the preparation of pharmaceutical compositions having utility in cardiac diseases" (primary filing date in Hungary: January, 2007; PCT filing date: January, 2008)

Licensing in:

We are interested in intellectual property releted to
  • peroxynitrite detection technologies
  • inhibition of cytotoxic actions of peroxynitrite
  • inhibititors of matrix metalloproteinases